Results 81 to 90 of about 6,142 (193)

sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial. [PDF]

Sci Rep
Smadja DM, Massonnaud CR, Philippe A, Rosa M, Luneau S, Rauch A, Peiffer-Smadja N, Gagneux-Brunon A, Poissy J, Gruest M, Ung A, Pourcher V, Raffi F, Piroth L, Bouiller K, Esperou H, Delmas C, Belhadi D, Diallo A, Saillard J, Dechanet A, Mercier N, Dupont A, Lescure FX, Goehringer F, Jaureguiberry S, Danion F, Tolsma V, Cabie A, Courjon J, Leroy S, Mootien J, Mourvillier B, Gallien S, Lanoix JP, Botelho-Nevers E, Wallet F, Richard JC, Reuter J, Gaymard A, Greil R, Martin-Blondel G, Andrejak C, Yazdanpanah Y, Burdet C, Diehl JL, Hites M, Ader F, Susen S, Mentré F, Dupont A, Discovery Study Group.   +51 more
europepmc   +1 more source

Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial. [PDF]

Clin Infect Dis
Terzić V, Miantezila Basilua J, Billard N, de Gastines L, Belhadi D, Fougerou-Leurent C, Peiffer-Smadja N, Mercier N, Delmas C, Ferrane A, Dechanet A, Poissy J, Espérou H, Ader F, Hites M, Andrejak C, Greil R, Paiva JA, Staub T, Tacconelli E, Burdet C, Costagliola D, Mentré F, Yazdanpanah Y, Diallo A, DisCoVeRy Study Group.   +25 more
europepmc   +1 more source

Crystal structure of Cs₂GdNb₆Cl₁₅O₃ in the structural evolution of niobium oxychlorides with octa-hedral Nb₆-cluster units. [PDF]

Acta Crystallogr E Crystallogr Commun, 2023
Silaban S, Silaban S, Haryani ME, Gulo F, Perrin C.   +4 more
europepmc   +1 more source

Augmented inventorship: rethinking patent law in the age of generative AI. [PDF]

J Law Biosci
Levy HV.
europepmc   +1 more source

A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab. [PDF]

Nat Commun
Blauvelt A, Jiang R, Shi L, Tsoi LC, Bogle R, Fox J, Gharaee-Kermani M, Billi AC, Matheson RT, Photowala H, Gudjonsson JE, Ehst BD.   +11 more
europepmc   +1 more source

Effectiveness and safety of polyacrylamide hydrogel injection for knee osteoarthritis: results from a 12-month follow up of an open-label study. [PDF]

J Orthop Surg Res
Bliddal H, Beier J, Hartkopp A, Conaghan PG, Henriksen M.   +4 more
europepmc   +1 more source

Oral splicing modulator branaplam in Huntington's disease: a phase 2 randomized controlled trial. [PDF]

Nat Med
Borowsky B, Ramos H, Caputo A, Hartmann A, Faller T, Peters T, Sui Y, Liu F, Meadowcroft M, David OJ, Laisney M, Kinhikar A, Marder KS, Tabrizi SJ, Landwehrmeyer GB, Leavitt BR.   +15 more
europepmc   +1 more source

A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Seifert J, Grohmann R, Toto S, Reinhard MA, Bleich S, Erfurth A, Schüle C, Stübner S, Glocker C.   +8 more
europepmc   +1 more source

Attributable Mortality to Candidiasis in Non-Neutropenic Critically Ill Patients in the ICU and a Post-Mortem Study. [PDF]

J Fungi (Basel)
Ibañez-Nolla J, Garcia F, Carrasco MA, Nolla-Salas M.   +3 more
europepmc   +1 more source

Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): Results from an observational pharmacovigilance program between 2000 and 2017. [PDF]

Addict Sci Clin Pract
Pauwels P, Haack B, Toto S, Seifert J, Grohmann R, Heinze M, Zolk O, Proskynitopoulos PJ, Schneider M, Greiner T.   +9 more
europepmc   +1 more source